Biotech, Pharma Stocks Weaker Amid Trump Comments on Lower Drug Prices
Biotech and Pharma stocks (NASDAQ: IBB) are seeing early weakness following comments from Donald Trump on drug pricing in his interview for Time Person of the Year.
"I'm going to bring down drug prices," he says. "I don't like what has happened with drug prices."
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Roblox (RBLX) Trades at Low, Down 8%
- Pullback in AI beneficiaries is 'a buying opportunity' - UBS
- Trian Sends Letter to Fellow Disney Shareholders Outlining the Need for Change
Create E-mail Alert Related Categories
Trader TalkRelated Entities
Donald J. TrumpSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!